Can Linvoseltamab Be Safely Combined with Anti-CD38 Antibodies? | Meletios Dimopoulos, MD

Can Linvoseltamab Be Safely Combined with Anti-CD38 Antibodies? | Meletios Dimopoulos, MD
Can Linvoseltamab Be Safely Combined with Anti-CD38 Antibodies? | Meletios Dimopoulos, MD
What I Learned at ASH as a Myeloma Patient: Personalized Care & Access | Valarie Traynham
What I Learned at ASH as a Myeloma Patient: Personalized Care & Access | Valarie Traynham
Defining Functional High-Risk Myeloma & Why Its Important | Barry Paul, MD & Todd Kennedy
Defining Functional High-Risk Myeloma & Why Its Important | Barry Paul, MD & Todd Kennedy
Join the Nutrivention 2 Study: Investigating a Plant Based Diet for MGUS or Smoldering Myeloma | Urvi Shah, MD
Join the Nutrivention 2 Study: Investigating a Plant Based Diet for MGUS or Smoldering Myeloma | Urvi Shah, MD
Highlights of Smoldering Multiple Myeloma from ASH25 | Mohamad Mohty, MD, PhD
Highlights of Smoldering Multiple Myeloma from ASH25 | Mohamad Mohty, MD, PhD
Long-term PFS updates on the CARTITUDE-4 Trial | Luciano Costa, MD
Long-term PFS updates on the CARTITUDE-4 Trial | Luciano Costa, MD
Daratumumab VS Lenalidomide maintenance therapy in Multiple Myeloma | Urvi Shah, MD
Daratumumab VS Lenalidomide maintenance therapy in Multiple Myeloma | Urvi Shah, MD
Does Diet Impact Treatment Response? Join NUTRIVENTION Study for Newly Diagnosed Myeloma | Urvi Shah, MD
Does Diet Impact Treatment Response? Join NUTRIVENTION Study for Newly Diagnosed Myeloma | Urvi Shah, MD
BETA - What is some of the most promising research being done to treat chronic lymphocytic leukemia?